Vanguard Group »

Protagenic Therapeutics Ord shares owned by Vanguard Group

Quarter-by-quarter ownership of Protagenic Therapeutics Ord (PTIX) shares owned by Vanguard Group from 13F filings

Historical chart of Vanguard Group investment in Protagenic Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Protagenic Therapeutics Ord held by Vanguard Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Protagenic Therapeutics Ord by Vanguard Group

Quarter filed Position value Share count Share price at filing
2023-12-31 $33k 33k 0.99
2023-09-30 $61k 33k 1.84
2023-06-30 $67k 33k 2.03
2023-03-31 $57k 33k 1.73

More positions owned by Vanguard Group

Apple (AAPL)
Microsoft Corporation (MSFT)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
Tesla Motors (TSLA)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
UnitedHealth (UNH)
Eli Lilly & Co. (LLY)
Exxon Mobil Corporation (XOM)
Visa Com Cl A (V)

View all positions for Vanguard Group

Top funds holding Protagenic Therapeutics Ord

Vanguard Group
FNY Investment Advisers
Wells Fargo & Company
Bank of America Corporation
CWM

View all funds holding Protagenic Therapeutics Ord